Roche: Lower the cost of your breast cancer drug so public health services can afford it!

Thirteen years ago, a five-year old boy told me all he wanted for Christmas was, “Just one thing, Auntie Margaret: Five minutes with my mummy."

It broke my heart - his wonderful mummy, Helen Mulhearn, had suffered an awful death 16 months before due to late-diagnosed breast cancer. At that time there were not many drugs that could have helped her. Then four and a half years ago, I was found to have breast cancer too. I was lucky - I was diagnosed early, and with standard breast cancer suitable for a drug that cost just pennies, thank God.

A new drug developed by Roche, one of the biggest pharmaceutical gains in the world, could help these young women with advanced breast cancer -- but Roche has priced the drug at £90,000, out of reach of both England and Scotland's public health services. When asked why this drug was so expensive, Jennifer Cozzone -- the head of pricing at Roche -- actually said it reflects the “value” to the patient, effectively shutting out low-income patients!

Sign our Care2 petition today, and call on Roche to reduce the price of KADCYLA to a level that all public health services can cover! This drug should be available as a matter of course!

Signera petitionen
Signera petitionen
Du har JavaScript inaktiverat. Utan den skulle vår webbplats inte fungera korrekt.

sekretesspolicy

genom att skriva under accepterar du användarvillkor för Care2
Du kan hantera dina epostabonnemang när som helst.

Har problem med att skriva under detta? Låt oss veta.